These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 15464183

  • 1. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial.
    de Kraker J, Graf N, van Tinteren H, Pein F, Sandstedt B, Godzinski J, Tournade MF, SIOP.
    Lancet; ; 364(9441):1229-35. PubMed ID: 15464183
    [Abstract] [Full Text] [Related]

  • 2. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
    Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Acha T, Godzinski J, Oldenburger F, Boccon-Gibod L, Leuschner I, Vujanic G, Sandstedt B, de Kraker J, van Tinteren H, Graf N, SIOP Renal Tumours Study Group.
    Lancet; 2015 Sep 19; 386(9999):1156-64. PubMed ID: 26164096
    [Abstract] [Full Text] [Related]

  • 3. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H, Semler O, Bürger D, Bode U, Flentje M, Göbel U, Gutjahr P, Leuschner I, Maass E, Niggli F, Scheel-Walter HG, Stöckle M, Thüroff JW, Tröger J, Weirich A, von Schweinitz D, Zoubek A, Graf N.
    Klin Padiatr; 2004 Sep 19; 216(3):132-40. PubMed ID: 15175957
    [Abstract] [Full Text] [Related]

  • 4. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
    Mitchell C, Pritchard-Jones K, Shannon R, Hutton C, Stevens S, Machin D, Imeson J, Kelsey A, Vujanic GM, Gornall P, Walker J, Taylor R, Sartori P, Hale J, Levitt G, Messahel B, Middleton H, Grundy R, Pritchard J, United Kingdom Cancer Study Group.
    Eur J Cancer; 2006 Oct 19; 42(15):2554-62. PubMed ID: 16904312
    [Abstract] [Full Text] [Related]

  • 5. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
    Tournade MF, Com-Nougué C, de Kraker J, Ludwig R, Rey A, Burgers JM, Sandstedt B, Godzinski J, Carli M, Potter R, Zucker JM, International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee.
    J Clin Oncol; 2001 Jan 15; 19(2):488-500. PubMed ID: 11208843
    [Abstract] [Full Text] [Related]

  • 6. Results of Wilms' tumour management in two tertiary-care hospitals in Asia.
    Sen S, Kadamba P, Al-AbdulAaly M, Mammen KE, Ahmed S.
    Pediatr Surg Int; 1998 Jan 15; 13(1):42-4. PubMed ID: 9391203
    [Abstract] [Full Text] [Related]

  • 7. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
    Graf N, van Tinteren H, Bergeron C, Pein F, van den Heuvel-Eibrink MM, Sandstedt B, Schenk JP, Godzinski J, Oldenburger F, Furtwängler R, de Kraker J.
    Eur J Cancer; 2012 Nov 15; 48(17):3240-8. PubMed ID: 22795263
    [Abstract] [Full Text] [Related]

  • 8. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
    Stefanowicz J, Sierota D, Balcerska A, Stoba C.
    Med Wieku Rozwoj; 2004 Nov 15; 8(2 Pt 1):197-200. PubMed ID: 15738594
    [Abstract] [Full Text] [Related]

  • 9. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Grundy PE, Malogolowkin M, Beckwith JB, Shamberger RC, Haase GM, Coppes MJ, Coccia P, Kletzel M, Weetman RM, Donaldson M, Macklis RM, Green DM.
    J Clin Oncol; 2006 May 20; 24(15):2352-8. PubMed ID: 16710034
    [Abstract] [Full Text] [Related]

  • 10. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.
    Ora I, van Tinteren H, Bergeron C, de Kraker J, SIOP Nephroblastoma Study Committee.
    Eur J Cancer; 2007 Jan 20; 43(1):131-6. PubMed ID: 17084075
    [Abstract] [Full Text] [Related]

  • 11. Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor.
    Tournade MF, Com-Nougué C, Voûte PA, Lemerle J, de Kraker J, Delemarre JF, Burgers M, Habrand JL, Moorman CG, Bürger D.
    J Clin Oncol; 1993 Jun 20; 11(6):1014-23. PubMed ID: 8388918
    [Abstract] [Full Text] [Related]

  • 12. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
    Daw NC, Chi YY, Kim Y, Mullen EA, Kalapurakal JA, Tian J, Khanna G, Geller JI, Perlman EJ, Ehrlich PF, Warwick AB, Grundy PE, Fernandez CV, Dome JS, AREN0321 Study Committee.
    Eur J Cancer; 2019 Sep 20; 118():58-66. PubMed ID: 31325873
    [Abstract] [Full Text] [Related]

  • 13. Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.
    Pritchard J, Imeson J, Barnes J, Cotterill S, Gough D, Marsden HB, Morris-Jones P, Pearson D.
    J Clin Oncol; 1995 Jan 20; 13(1):124-33. PubMed ID: 7799012
    [Abstract] [Full Text] [Related]

  • 14. From upfront nephrectomy to preoperative chemotherapy and back: a single institution experience in the treatment of Wilms tumor.
    Sultan I, Masarweh M, Ismael T, Al-Hussaini M, Almousa A, Ali HM, Rodriguez-Galindo C, Ghandour K.
    J Pediatr Hematol Oncol; 2009 May 20; 31(5):333-8. PubMed ID: 19415012
    [Abstract] [Full Text] [Related]

  • 15. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM, Breslow NE, Beckwith JB, Finklestein JZ, Grundy PE, Thomas PR, Kim T, Shochat SJ, Haase GM, Ritchey ML, Kelalis PP, D'Angio GJ.
    J Clin Oncol; 1998 Jan 20; 16(1):237-45. PubMed ID: 9440748
    [Abstract] [Full Text] [Related]

  • 16. Risks and benefits of percutaneous biopsy and primary chemotherapy in advanced Wilms' tumour.
    Dykes EH, Marwaha RK, Dicks-Mireaux C, Sams V, Risdon RA, Duffy PG, Ransley PG, Pritchard J.
    J Pediatr Surg; 1991 May 20; 26(5):610-2. PubMed ID: 1648128
    [Abstract] [Full Text] [Related]

  • 17. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM, Beckwith JB, Breslow NE, Faria P, Moksness J, Finklestein JZ, Grundy P, Thomas PR, Kim T, Shochat S.
    J Clin Oncol; 1994 Oct 20; 12(10):2126-31. PubMed ID: 7931483
    [Abstract] [Full Text] [Related]

  • 18. [Preoperative chemotherapy of nephroblastoma. Preliminary results of the SIOP-9/GPO therapy study].
    Ludwig R, Weirich A, Pötter R, Harms D, Bürger D, Michaelis J, Erttmann R, Weinel P, Haas RJ, Ritter J.
    Klin Padiatr; 1992 Oct 20; 204(4):204-13. PubMed ID: 1325574
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of advanced Wilms' tumor].
    Li MJ, Huang Y, Tang DX, Zhou YB, Tang HF, Liang JF.
    Zhonghua Zhong Liu Za Zhi; 2006 Oct 20; 28(10):791-5. PubMed ID: 17366799
    [Abstract] [Full Text] [Related]

  • 20. [Adjuvant chemotherapy in the combined modality therapy of nephroblastoma in children].
    Badalian GKh, Lebedev VI.
    Vopr Onkol; 1988 Oct 20; 34(11):1355-9. PubMed ID: 2849246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.